Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
Andrea Pession, Fraia Melchionda, Claudia CastelliniOncologia Ematologia Pediatrica “Lalla Seràgnoli”, Clinica Pediatrica, Università degli Studi di Bologna, Bologna, ItalyAbstract: Along with hydration and urinary alkalinization, allopurinol...
Enregistré dans:
Auteurs principaux: | Andrea Pession, Fraia Melchionda, Claudia Castellini |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c4b726773fb0479fa170b61d8acf5fbd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Urate oxidase purification by salting-in crystallization: towards an alternative to chromatography.
par: Marion Giffard, et autres
Publié: (2011) -
Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout
par: Philip K. Tan, et autres
Publié: (2017) -
The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion
par: Kazi Mirajul Hoque, et autres
Publié: (2020) -
Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia
par: Yao Xue, et autres
Publié: (2021) -
Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice
par: Maimaiti Yisireyili, et autres
Publié: (2017)